コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 he surface of Tregs stimulated through their T cell receptor.
2 ngths between a self-peptide and the various T cell receptors.
3 bles the binding of human CD1c self-reactive T-cell receptors.
4 a lentiviral vector expressing HCV-specific T-cell receptors.
5 inding of the Fc region of these proteins to T cells receptors.
8 be Ca(2+) signals reported by Salsa6f during T cell receptor activation in naive T cells, helper Th17
11 inated phosphatase activities at the site of T-cell receptor activation, which is important for limit
12 ansgenically expressing the diabetogenic AI4 T-cell receptor adoptively transferred disease to otherw
13 arcinoma and express a limited repertoire of T-cell receptors against tumour-associated antigens.
14 intained CD62L expression when activated via T cell receptor alone or in combination with costimulato
15 both by the germline encoded elements of the T cell receptor alpha and beta chain and, surprisingly,
17 ow that directing a CD19-specific CAR to the T-cell receptor alpha constant (TRAC) locus not only res
18 s a tool to classify and number antibody and T-cell receptor amino-acid variable domain sequences.
19 persistence and antitumor effects in murine T cell receptor and chimeric antigen receptor gene thera
20 the immunological synapse together with the T cell receptor and enhances the T cell receptor-induced
22 1/Ndfip2 regulate the cross talk between the T-cell receptor and cytokine signalling pathways to limi
24 y recognize peptide/MHC complexes with their T-cell receptors and initiate adaptive immune responses.
25 nding to CD3, the signaling component of the T-cell receptor, and a tumor target have shown clinical
26 ytotoxic T-lymphocyte-associated protein 4), T-cell receptor, and Csnk2b-related pathways in regulati
28 were reconstituted with HIV Env gp120, anti-T cell receptor (anti-TCR) monoclonal antibody, and ICAM
29 ined potent inhibitory activity that reduced T-cell receptor, B-cell receptor, and interferon signali
31 60% of cells have recombined the DNA of one T cell receptor beta (TCRbeta) V-to-DJ-joined allele in
32 sequencing to compare the global changes in T cell receptor beta chain complementarity determining r
33 , using mice expressing one of two different T cell receptor beta chains and various MHC alleles, we
35 ased on the mutually exclusive expression of T cell receptor beta-chain constant domains 1 and 2 (TRB
36 tarity-determining-region 3 (CDR3) of mature T-cell receptor beta (TCRB) can be used as an immune DNA
37 ytokines when stimulated with FVIII2194-2213 T-cell receptor beta (TCRB) gene sequencing of 15 T-cell
38 r CD8+ T-cells subsets were reconstituted in T-cell receptor beta knockout mice by adoptive transfer,
40 ed by vector integration site sequencing and T-cell receptor beta-chain rearrangement sequencing, cor
43 the interaction between MHC-II molecule and T-cell receptor but also, critically, by promoting B7-2/
44 disruption of Lck kinase, PLC-gamma1 or the T cell receptor complex inhibits light-evoked Ca(2+) tra
47 ic monoclonal antibodies (mAb) targeting the T-cell receptor coregulatory molecule GITR exert potent
50 n activated T cells, and ultimately augments T-cell-receptor-dependent production of interleukin 2 by
53 reminiscent of mechanical regulation of the T-cell receptor, E-cadherin, and Notch pathways, suggest
54 wn that Foxo3 expression was increased after T cell receptor engagement and played a specific role in
58 shorter telomeres but increased single-joint T-cell receptor excision circle content and CD31(+) naiv
61 finities of PD-1 are as high as those of the T cell receptor for agonist pMHC and of LFA-1 (lymphocyt
62 ells in the lamina propria and activation of T cell receptor gammadelta-expressing intraepithelial ly
63 associated with CMV and EBV infections, and T-cell receptor gammadelta(+) T cells were predominantly
64 cell subsets (CD4, CD8, WC-1, and gammadelta T cell receptor [gammadelta-TCR]) and cytokines examined
65 cytometry, examination of blood smears, and T cell receptor gene rearrangements), and performed musc
66 ral virologic control by sequencing viruses, T cell receptor genes, HIV integration sites, and cellul
67 Quantitative next generation sequencing of T-cell receptor genes revealed distinct oligoclonal CD4(
68 tigen receptors of jawed vertebrates (B- and T-cell receptors), heterodimers formed by pairs of Ig do
69 ndard MRD monitoring based on immunoglobulin/T-cell receptor (Ig/TCR) gene rearrangements and with qu
71 ient NOD mice showed significantly decreased T-cell receptor-induced IL-2, IFN-gamma, and GM-CSF expr
72 that positive selection-induced MHC bias of T cell receptors is affected both by the germline encode
74 ntigen, the non germline encoded elements of T cell receptors may help the proteins cope with the ext
76 n patients with HCV infection in response to T-cell receptor-mediated but not cytokine-mediated stimu
80 pment were associated with the expression of T cell receptor of higher functional avidity for self-an
82 thetic chimeric antigen receptors or natural T-cell receptors of diverse specificities provides engin
83 , but self-antigens presented by CD1c to the T-cell receptors of these cells are poorly understood.
84 T cells as an important subset of alphabeta T cell receptor-positive cells residing in mouse kidney.
88 e used to study host gene expression, B-cell/T-cell receptor profiles (BCR/TCR), and potential viral
89 racterized by expression of a semi-invariant T-cell receptor, rapidly produce copious amounts of dive
91 sed, and 1-DER T cells carrying a transgenic T-cell receptor reactive to Der p 1 allergen were used a
95 lls/muL, CD45RA < 10%, or a restricted Vbeta T-cell receptor repertoire (<13 of 24 families) were ass
96 differentiation resulting in an oligoclonal T-cell receptor repertoire and enhanced cytokine secreti
98 . reuteri did not shape the DP-IEL-TCR (TCR, T cell receptor) repertoire but generated indole derivat
99 munological functions, including antigen and T cell receptor repertoires, mechanisms of nonpeptidic a
100 son with WT mice, AQP4(-/-) mice used unique T-cell receptor repertoires for recognition of these two
101 uencing (WES), RNA sequencing (RNA-seq), and T cell receptor sequencing (TCR-seq) of pretreatment tum
103 the major histocompatibility complex and the T cell receptor (Signal 1) and between CD80 or CD86 and
104 In the face of persistent antigen, chronic T cell receptor signaling drives T lymphocytes to a func
106 remodeling (ARHGEF3), RNA splicing (U2AF1), T-cell receptor signaling (PTPRN2, RLTPR), and T-cell di
107 cts in immune cells including suppression of T-cell receptor signaling and promoting efficient produc
109 f Sevenless (SOS) networks, derived from the T-cell receptor signaling system, on supported membranes
110 ly critical in Treg, acting there to control T-cell receptor signaling, cell proliferation, and survi
111 SFK SH2 domains in kinase autoinhibition and T-cell receptor signaling, monobodies binding the Src an
114 thymocyte survival such as RORgammat and for T-cell receptor signalling including Zap70 and CD8, thro
115 Protein kinase-A activation downstream of T-cell receptor signalling inhibits macroautophagy upon
117 microscopy and T cells transfected with the T-cell receptor specific for the birch pollen allergen B
118 ion using flow cytometry, immunoglobulin and T-cell receptor spectratyping, and deep sequencing of im
119 croRNA content in EVs released upon in vitro T cell receptor stimulation of Th1, Th17, and T regulato
123 g enough to discriminate pMHC half-lives and T cell receptor (TCR) accumulation selectively stabilize
124 g pathway on model membranes, beginning with T cell receptor (TCR) activation and ending with actin a
125 old CD8+ T cells expressing clonal anti-H2K T cell receptor (TCR) alloreactive for MHC I, graft surv
126 the H3.3K27M mutation, complementary DNA for T cell receptor (TCR) alpha- and beta-chains were cloned
127 ccordance with the requirement that both the T cell receptor (TCR) and CAR be engaged to accelerate T
128 izing high-throughput screening (HTS) of the T cell receptor (TCR) and immunostaining, we found that
129 gation on exhausted CD8(+) T cells inhibited T cell receptor (TCR) and interleukin-2 (IL-2) signaling
131 ry of this cell-cell interface, within which T cell receptor (TCR) and peptide major histocompatibili
132 on of genes associated with Notch receptors, T cell receptor (TCR) assembly, and TCR-mediated signali
133 olecule), and physically associates with the T cell receptor (TCR) at the center of the immunological
134 ne whether intratumoral and peripheral blood T cell receptor (TCR) clonality inform clinical outcomes
135 cells are activated through ligation of the T cell receptor (TCR) complex, leading to the induction
136 lly promoting allorecognition either through T cell receptor (TCR) crossreactivity or independently f
137 r TH cells, exhibit delayed receptor-induced T cell receptor (TCR) downmodulation, enhanced TCR signa
138 The activation of NF-kappaB downstream of T cell receptor (TCR) engagement is a key signaling step
139 nse by measuring the binding strength of its T cell receptor (TCR) for peptide-loaded MHCs (pMHC) on
140 Although antigen recognition mediated by the T cell receptor (TCR) influences many facets of Foxp3(+)
143 develop from DP cells after partial-agonist T cell receptor (TCR) interactions with self-peptide/MHC
144 activation following antigen binding to the T cell receptor (TCR) involves the mobilization of intra
145 provides a critical second signal alongside T cell receptor (TCR) ligation for naive T cell activati
146 We discovered a non-MHC-linked Ir gene in a T cell receptor (TCR) locus that was required for CD8(+)
147 a hepatitis B virus-specific (HBV-specific) T cell receptor (TCR) may supplement HBV-specific immune
150 rom high affinity agonist recognition by the T cell receptor (TCR) or from a death receptor, such as
151 nnate-like T cells expressing the gammadelta T cell receptor (TCR) rather than the alphabeta TCR coul
153 l compartment must contain diversity in both T cell receptor (TCR) repertoire and cell state to provi
154 exhibited mature naive phenotypes, a diverse T cell receptor (TCR) repertoire and TCR-dependent funct
160 chnology, but these animals contain a biased T cell receptor (TCR) repertoire that might affect immun
164 ese individual cells, coupled with assembled T cell receptor (TCR) sequences, enable us to identify 1
168 previously demonstrated that Tpl2 regulates T cell receptor (TCR) signaling and modulates T helper c
169 e underscore temporal integration of digital T cell receptor (TCR) signaling as the basis for achievi
172 This is potentially attributed to decreased T cell receptor (TCR) signaling strength due to ineffici
175 by a fate-determination process mediated via T cell receptor (TCR) signals for differentiation into d
176 atibility complex (MHC)-restricted alphabeta T cell receptor (TCR) T cells and non-MHC-restricted gam
180 ed a broad repertoire of target antigens and T cell receptor (TCR) usage, with initial evidence of pu
181 v) MAIT cell responses to SEB can occur in a T cell receptor (TCR) Vbeta-specific manner but are larg
182 n-specific recognition by T cells is via the T cell receptor (TCR) which is unique for each T cell.
183 ns, T cells interact through their alphabeta T cell receptor (TCR) with peptide-major histocompatibil
185 rentiate in response to signals engaging the T cell receptor (TCR), express high levels of the immuno
186 ned by a heterodimeric surface receptor, the T cell receptor (TCR), that mediates recognition of path
187 differentiation, namely on the role of both T cell receptor (TCR)-dependent and TCR-independent fact
188 e (IP3) production, leading to a decrease in T cell receptor (TCR)-dependent intracellular Ca(2+) res
190 ar potassium concentration ([K(+)]e) impairs T cell receptor (TCR)-driven Akt-mTOR phosphorylation an
191 ipheral tissues, SFB selectively expand dual T cell receptor (TCR)-expressing Th17 cells recognizing
192 producing the cytokine when stimulated in a T cell receptor (TCR)-independent manner but failed to d
194 t studies have identified several subsets of T cell receptor (TCR)-negative IELs with intriguing prop
197 cytotoxic lymphocytes, derived from innate, T cell receptor (TCR)alphabeta, and TCRgammadelta lineag
198 mmunology as T cells activated through their T cell receptors (TCR) by protein antigens orchestrate i
200 limit T-cell efficacy, including suboptimal T-cell receptor (TCR) activation and an immunosuppressiv
203 m human IgA CH3, IgD CH3, IgG1 CH3, IgM CH4, T-cell receptor (TCR) alpha/beta, and TCR gamma/delta co
204 al or mMUD HSCT after depleting GvHD-causing T-cell receptor (TCR) alphabeta CD3(+) cells from the gr
205 uction of IgE synthesis is transferable with T-cell receptor (TCR) alphabeta(+)CD4(+)CD25(-) cells, w
209 or histocompatibility class II molecules and T-cell receptor (TCR) beta-chain variable domains (Vbeta
210 ncy is initiated in early thymocytes, before T-cell receptor (TCR) beta-rearrangement, which is bypas
213 ed MHC class II (MHC-II) gene, HLA-DR2a, and T-cell receptor (TCR) genes specific for MBP87-99/DR2a t
214 ically modified to express a cancer-specific T-cell receptor (TCR) has shown significant therapeutic
215 h recognizes insulin B15-23 via an alphabeta T-cell receptor (TCR) incorporating TRAV8-1/TRAJ9 and TR
216 revealed that repetitive stimulation of the T-cell receptor (TCR) induced AICD, as a result of activ
219 s), created by transduction of a recombinant T-cell receptor (TCR) isolated from a hemophilia A subje
220 lls comprise a first line of defense through T-cell receptor (TCR) recognition of stressed cells.
222 nflicting literature on the diversity of the T-cell receptor (TCR) repertoire in lesional AD, and its
225 mponents of T-cell tolerance, which includes T-cell receptor (TCR) self-reactivity, costimulation, cy
228 tion with high-risk HLA genes using a direct T-cell receptor (TCR) sequencing approach without long-t
230 ivirus (formerly named GBV-C) interfere with T-cell receptor (TCR) signaling by novel RNA and protein
232 ffinity T cells missed by tetramers, using a T-cell receptor (TCR) signalling reporter and micropipet
233 itive (DP) thymocytes respond to intrathymic T-cell receptor (TCR) signals by undergoing positive sel
234 uates the NF-kappaB signal transduction upon T-cell receptor (TCR) stimulation by specifically suppre
236 -specific CD8 T cells in vitro with a second T-cell receptor (TCR) that recognizes a bacterial antige
239 ch the interaction of a clonotypic alphabeta T-cell receptor (TCR) with a peptide-loaded major histoc
241 unotherapy, we isolated an HLA-A2-restricted T-cell receptor (TCR) with high avidity for human TERT f
243 arization of the centrosome were unaffected, T-cell receptor (TCR)-mediated signaling and recruitment
244 owever, common Treg expansion approaches use T-Cell Receptor (TCR)-mediated stimulation which also ca
247 Strikingly, we found that antigen receptor [T-cell receptor (TCR)] signaling regulates this process
248 Negative selection purges thymocytes whose T-cell receptors (TCR) exhibit high affinity to self-pep
251 cell activation by linking antigen receptor (T cell receptor, TCR) signals to downstream pathways.
254 en (pHLA) to screen for antigens of "orphan" T cell receptors (TCRs) expressed on TILs from human col
255 of T cells is mediated by the engagement of T cell receptors (TCRs) followed by calcium entry via st
256 ow co-crystal structures of MR1 complexed to T cell receptors (TCRs) from two classes of MAIT-type ce
258 d lymphocytes expressing neoantigen-specific T cell receptors (TCRs) isolated from peripheral blood r
259 we investigated the clonal diversity of the T cell receptors (TCRs) of infiltrating IFN-gamma and IL
261 (MAIT) cells is the expression of TRAV1-2(+) T cell receptors (TCRs) that are activated by riboflavin
262 During thymic selection, T cells bearing T cell receptors (TCRs) with high affinity for self-anti
263 domains of immune receptors (antibodies and T cell receptors (TCRs)) is of key importance in the und
264 ures can be identified by documenting public T cell receptors (TCRs), we profiled the T cell repertoi
268 Glycolipid antigens recognized by alphabeta T-cell receptors (TCRs) drive the activation of invarian
269 ls receiving T cells expressing SIV-specific T-cell receptors (TCRs) had significantly fewer viral ge
270 red to express chimeric antigen receptors or T-cell receptors (TCRs) has demonstrated clinical effica
272 we sought to identify the alpha-beta paired T-cell receptors (TCRs) of tumor-infiltrating lymphocyte
273 nity-maturation campaigns for antibodies and T-cell receptors (TCRs) operate on the residues at the b
274 mpatibility complex (MHC) class I-restricted T-cell receptors (TCRs) or chimeric antigen receptors to
278 Previous studies have demonstrated that T-cell receptors (TCRs) that focus on a minimal motif wi
279 A-A2 produce cytotoxic T lymphocytes bearing T-cell receptors (TCRs) that recognize the immunodominan
280 lymphocytes use surface [Formula: see text] T-cell receptors (TCRs) to recognize peptides bound to M
281 relatively weak affinity of most anti-cancer T-cell receptors (TCRs), there is growing emphasis on im
282 We bred miR-146a-deficient mice with 2D2 T cell receptor-Tg mice to generate 2D2 CD4 T cells that
283 , such as chimeric antigen and high-affinity T-cell receptors to deepen the adaptive immune response;
284 patic cytokines, and (via the semi-invariant T-cell receptor) to bacteria translocated from the gut.
285 esent peptides to T cells displaying a large T-cell receptor (TR) repertoire, MH1Like proteins, such
286 gen presentation from DCs to CD4(+) T cells (T cell receptor transgenic OT-II) was measured via a [(3
287 acities of B cells were studied by using new T-cell receptor transgenic 1-DER mice specific for the D
289 insulin B-chain-specific CTL from different T-cell receptor transgenic mice (G9Calpha(-/-)) expressi
293 nant T cells expressing an SEA-nonresponsive T-cell receptor variable region beta chain are nonrespon
294 roduced high levels of IL-10 and had diverse T cell receptor Vbeta repertoires with an oligoclonal ex
299 ses in this pathway, Lck and ZAP-70, for the T cell receptor zeta chain and the scaffold proteins LAT
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。